 |
|
|
|
|
|
|
| Article 1 to 9 out of 9 concerning Barr Pharmaceuticals, Inc.
|
-
PLIVA Announces Changes in Management and Supervisory Boards
(02 Nov 2006)
PLIVA's Supervisory Board Appoints Three New Members to Management Board
Barr Pharmaceuticals, Inc. and its newly acquired subsidiary PLIVA d.d. announced changes to the Management and Supervisory Boards of PLIVA d.d. The changes resulted from the meeting of PLIVA's Supervisory Board that was held on October 30, 2006 in ...
-
Actavis divests its stake in PLIVA
(24 Oct 2006)
Actavis Group announced that a total of 20.8% of PLIVA's share capital that Actavis controls through a combination of share ownership and options to acquire shares has been tendered into Barr's offer to acquire all outstanding shares in PLIVA at ...
-
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
(23 Oct 2006)
Barr Pharmaceuticals, Inc. and PLIVA d.d. announced that the Central Depository Agency ("CDA") has issued the final results of the tender process and that 17,056,977 shares, representing 92% of PLIVA's share capital, have been tendered to Barr's ...
-
Actavis responds to Barr Pharmaceuticals' increased offer for PLIVA
(20 Sep 2006)
Actavis Group has noted the increased offer published on September 11th, to acquire PLIVA, announced by Barr Pharmaceuticals.The Board of Actavis believes that its current offer of HRK 795 per share represents a full and fair price for PLIVA's ...
-
Barr Names G. Frederick Wilkinson President and COO of Duramed Pharmaceuticals, Inc.
(12 Jan 2006)
Paul M. Bisaro Named President, Barr Pharmaceuticals, Inc.
Barr Pharmaceuticals, Inc. announced that G. Frederick Wilkinson has agreed to join the Company as President and Chief Operating Officer of Duramed Pharmaceuticals, Inc., Barr's proprietary products subsidiary. In this position, Wilkinson will be ...
-
Barr Confirms Patent Challenge of Razadyne(R) Tablets
(20 Jun 2005)
Barr Pharmaceuticals, Inc. confirmed that Janssen Pharmaceutica Products, L.P. and Synaptech filed suit against the Company's subsidiary, Barr Laboratories, Inc., in the District Court of Delaware, relating to the patents protecting Razadyne(R) ...
-
Schering AG files patent infringement lawsuit against Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc.
(03 May 2005)
Schering AG, Germany announced that it has, along with its affiliate, Berlex, Inc., filed a patent infringement action against Barr Laboratories, Inc. and its parent company Barr Pharmaceuticals, Inc. relating to Schering AG's YasminŽ (drospirenone ...
-
Court Grants Barr Summary Judgment in DDAVP(R) Patent Challenge
(14 Feb 2005)
Barr Pharmaceuticals, Inc. announced that the U.S. District Court for the Southern District of New York has granted summary judgment in favor of its wholly owned subsidiary, Barr Laboratories, Inc., in the Company's challenge to the patents for ...
-
Barr Sues FDA to Obtain Sole Exclusivity on Allegra-D(R)
(10 Feb 2005)
Barr Pharmaceuticals, Inc. announced that its subsidiary, Barr Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration (FDA) in the United States District Court for the District of Columbia. Barr's suit challenges FDA's ...
|
|
|
|
|
Top